Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Wall Street Zen's Rating of Vicore Pharma on 10/24/2026

On October 24, 2026, Wall Street Zen updated its outlook on Vicore Pharma (NASDAQ:VCRE) with the action "Upgrade", setting a "Hold" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Wall Street Zen

DateCompanyAction
10/24/2026
Once Upon A Farm stock logo
OFRM
Once Upon A Farm
Downgrade
10/24/2026
Klarna Group plc stock logo
KLAR
Klarna Group
Downgrade
10/24/2026
Infleqtion stock logo
INFQ
Infleqtion
Downgrade
10/24/2026
Biohaven Ltd. stock logo
BHVN
Biohaven
Upgrade
10/24/2026
ECB Bancorp, Inc. stock logo
ECBK
ECB Bancorp
Upgrade
10/24/2026
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
Downgrade
More Ratings From Wall Street Zen